Omnicell Net Worth 2010-2024 | OMCL

Interactive chart of historical net worth (market cap) for Omnicell (OMCL) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Omnicell net worth as of May 13, 2025 is $1.31B.
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.312B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.242B 54.20
Hims & Hers Health (HIMS) United States $14.325B 148.84
Tempus AI (TEM) United States $11.867B 0.00
Inspire Medical Systems (INSP) United States $4.712B 73.62
IRhythm Technologies (IRTC) United States $4.463B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.134B 11.90
Clover Health Investments (CLOV) United States $1.737B 0.00
Schrodinger (SDGR) United States $1.735B 0.00
Phreesia (PHR) United States $1.534B 0.00
Azenta (AZTA) United States $1.277B 59.36
10x Genomics (TXG) United States $1.180B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.589B 0.00
Talkspace (TALK) United States $0.514B 153.50
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.433B 0.00
Claritev (CTEV) United States $0.405B 0.00
TruBridge (TBRG) United States $0.375B 831.67
Health Catalyst (HCAT) United States $0.299B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.208B 0.00
Nyxoah SA (NYXH) Belgium $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.156B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
American Well (AMWL) United States $0.119B 0.00
MDxHealth SA (MDXH) Belgium $0.084B 0.00
CareCloud (CCLD) United States $0.084B 3.19
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
Outset Medical (OM) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00